Population pharmacokinetics/pharmacodynamics modelling of enrofloxacin for the three major trout pathogens Aeromonas salmonicida, Flavobacterium psychrophilum and Yersinia ruckeri

Autor: Catherine Fournel, Sandrine Baron, Patrick Daniel, Chantal Thorin, Alexis Viel, Marie-Line Morvan, Pascal Sanders, Antoine Rostang, Ségolène Calvez

Publikováno v: Aquaculture
Aquaculture, Elsevier, 2021, 545, pp.737119. ⟨10.1016/j.aquaculture.2021.737119⟩

International audience; Enrofloxacin is a fluoroquinolone antimicrobial agent used in freshwater rainbow trout against the main pathogenic bacteria Aeromonas salmonicida, Yersinia ruckeri and Flavobacterium psychrophilum. However, the current “stan

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05db693c1ae7d8f6766d067ccc9ae964
https://hal-anses.archives-ouvertes.fr/anses-03318243

Antibiotic allergy as a cause of hospitalization in adults: a hospital-based study in Ukraine

Autor: A. B. Zimenkovsky, Oksana Horodnycha

Publikováno v: Pharmacy Practice (Granada) v.19 n.1 2021
SciELO España: Revistas Científicas Españolas de Ciencias de la Salud
Instituto de Salud Carlos III (ISCIII)
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Pharmacy Practice, Vol 19, Iss 1, p 2055 (2021)
Pharmacy Practice

Background: Antibiotic allergy is an important clinical and social-economical issue. Objective: The main objectives of this study were to determine the incidence, causative drugs, and risk groups of antibiotic allergy as a reason for hospitalization.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2c8e7935e8233f6e274a6fe092d15d1
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1885-642X2021000100002

Is 5 days of oral fluoroquinolone enough for acute uncomplicated pyelonephritis? The DTP randomized trial

Autor: A. Davido, Frédérique Bouchand, G. Der Sahakian, E. Mathieu, X. Ranchoux, Joshua A. Salomon, T. A. Szwebel, N. Sembach, A. Dinh, C. Jordy, Louis Bernard, B. Davido, A. Raynaud-Lambinet, E. Aslangul-Castier, M. Etienne, Clara Duran

Publikováno v: European Journal of Clinical Microbiology and Infectious Diseases
European Journal of Clinical Microbiology and Infectious Diseases, Springer Verlag, 2017, 36 (8), pp.1443-1448. ⟨10.1007/s10096-017-2951-6⟩
European Journal of Clinical Microbiology and Infectious Diseases, 2017, 36 (8), pp.1443-1448. ⟨10.1007/s10096-017-2951-6⟩

International audience; The treatment duration of acute uncomplicated pyelonephritis (AUP) is still under debate. As shortening treatment duration could be a means to reduce antimicrobial resistance, we aimed to establish whether 5 days of antibiotic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5cd47133cbb14b84ba61c7081593f33
https://hal-normandie-univ.archives-ouvertes.fr/hal-02372862

Pharmacokinetic/Pharmacodynamic Analysis of the Influence of Inoculum Size on the Selection of Resistance in Escherichia coli by a Quinolone in a Mouse Thigh Bacterial Infection Model

Autor: Pierre-Louis Toutain, Alain Bousquet-Mélou, Anne-Sylvie Kesteman, Aude A. Ferran

Publikováno v: Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2009, 53 (8), pp.3384-90. ⟨10.1128/AAC.01347-08⟩

Maintaining quinolone concentrations outside the mutant selection window (MSW) between the MIC and mutant prevention concentration (MPC) was suggested by in vitro and in vivo studies to prevent the selection of resistant mutants. However, selection a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be64c6bd7ef8bdb661c0298b904d9a9e
https://doi.org/10.1128/aac.01347-08

Enrofloxacin and marbofloxacin in horses: comparison of pharmacokinetic parameters, use of urinary and metabolite data to estimate first-pass effect and absorbed fraction

Autor: Alain Bousquet-Mélou, Valérie Laroute, Mathieu Peyrou, André Vrins, Michèle Doucet

Publikováno v: Journal of Veterinary Pharmacology and Therapeutics
Journal of Veterinary Pharmacology and Therapeutics, Wiley-Blackwell, 2006, 29 (5), pp.337-44. ⟨10.1111/j.1365-2885.2006.00752.x⟩

International audience; Enrofloxacin and marbofloxacin are two veterinary fluoroquinolones used to treat severe bacterial infections in horses. A repeated measures study has been designed to compare their pharmacokinetic parameters, to investigate th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccde4b55c8e83247c7d4bee2daf96236
https://doi.org/10.1111/j.1365-2885.2006.00752.x